From: Development and validation of an extended Cox prognostic model for patients with ER/PR+ and HER2− breast cancer: a retrospective cohort study
AUC
95% CI
1 year
0.85
0.78 to 0.93
3 years
0.94
0.89 to 0.99
5 years
0.81
0.68 to 0.94